Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
- DOI
- 10.1056/nejm199811193392101
- Published
- 1998 Nov 19
- Container
- The New England journal of medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1056/nejm199811193392101,
title = {Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.},
author = {McHutchison JG and Gordon SC and Schiff ER and Shiffman ML and Lee WM and Rustgi VK and Goodman ZD and Ling MH and Cort S and Albrecht JK},
year = {1998},
journal = {The New England journal of medicine},
doi = {10.1056/nejm199811193392101},
url = {https://doi.org/10.1056/nejm199811193392101}
}RIS
TY - JOUR TI - Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. AU - McHutchison JG AU - Gordon SC AU - Schiff ER AU - Shiffman ML AU - Lee WM AU - Rustgi VK AU - Goodman ZD AU - Ling MH AU - Cort S AU - Albrecht JK PY - 1998 JO - The New England journal of medicine DO - 10.1056/nejm199811193392101 UR - https://doi.org/10.1056/nejm199811193392101 ER -
APA
JG, M., SC, G., ER, S., ML, S., WM, L., VK, R., ZD, G., MH, L., S, C., & JK, A. (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.. The New England journal of medicine. https://doi.org/10.1056/nejm199811193392101
Source records
- pubmed · retrieved 2026-11-10T14:09:04.910Z